Syneron Medical Ltd. Research and Development Expense
Syneron Medical Ltd. reported Research and Development Expense of $23.04 million for the 12-month period ending 2016-12-31, per its 20-F filed 2017-03-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2017-03-23
| Period end | Research and Development Expense 12 month |
|---|---|
| 2016-12-31 | $23.04M 20-F · filed 2017-03-23 |
| 2015-12-31 | $25.27M 20-F · filed 2017-03-23 |
| 2014-12-31 | $24.62M 20-F · filed 2017-03-23 |
| 2013-12-31 | $30.00M 20-F · filed 2016-03-21 |
| 2012-12-31 | $29.94M 20-F · filed 2015-03-24 |
| 2011-12-31 | $28.33M 20-F · filed 2014-03-19 |
| 2010-12-31 | $26.84M 20-F · filed 2013-03-21 |
| 2009-12-31 | $13.22M 20-F/A · filed 2012-09-27 |